Leite John 4
4 · VERACYTE, INC. · Filed Mar 6, 2026
Research Summary
AI-generated summary of this filing
Veracyte (VCYT) CCO John Leite Sells 5,260 Shares
What Happened John Leite, Chief Commercial Officer (CLIA) of Veracyte, sold 5,260 shares of VCYT stock on March 4, 2026. The weighted average sale price was $35.19, for total proceeds of approximately $185,083. The sale was reported on Form 4 filed March 6, 2026 and is reported as an open‑market/private sale (code S).
Key Details
- Transaction date: 2026-03-04; Form 4 filed: 2026-03-06 (timely filing).
- Shares sold: 5,260; weighted average price: $35.19; total proceeds ≈ $185,083.
- Price range for individual lots: $35.00 to $35.53 (weighted average reported; breakdown available on request per footnote).
- Sale executed pursuant to a prearranged Rule 10b5‑1 trading plan adopted by Mr. Leite on June 9, 2025 (per footnote).
- Shares owned after the transaction: not specified in the provided filing.
Context This was a sale under a 10b5‑1 plan, which typically indicates a preplanned, scheduled disposition rather than a spontaneous market signal. Sales are common for insiders for liquidity or diversification and are generally less informative than purchases about insider confidence in the company.
Insider Transaction Report
Form 4
VERACYTE, INC.VCYT
Leite John
Chief Commercial Officer-CLIA
Transactions
- Sale
Common Stock
[F1][F2]2026-03-04$35.19/sh−5,260$185,083→ 107,580 total
Footnotes (2)
- [F1]The transaction on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 9, 2025.
- [F2]Represents weighted average sales price. Sale prices for the transactions range from $35.00 to $35.53. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Signature
/s/ Jonathan Wygant as attorney-in-fact|2026-03-06